Pulmonary thromboendarterectomy after treatment with treprostenil in a chronic thromboembolic pulmonary hypertension patient: a case report

Konstantinos Porpodis1 Pulmonary Department, “G Papanikolaou” General Hospital, Aristotle University of Thessaloniki, Greece

Maria Konoglou2 First Pulmonary Clinic, “G Papanikolaou” General Hospital, Thessaloniki, Greece

Paul Zarogoulidis1 Pulmonary Department, “G Papanikolaou” General Hospital, Aristotle University of Thessaloniki, GreeceCorrespondence[email protected]

Evangelos Kaimakamis2 First Pulmonary Clinic, “G Papanikolaou” General Hospital, Thessaloniki, Greece

Theodoros Kontakiotis1 Pulmonary Department, “G Papanikolaou” General Hospital, Aristotle University of Thessaloniki, Greece

Despoina Papakosta1 Pulmonary Department, “G Papanikolaou” General Hospital, Aristotle University of Thessaloniki, Greece

Vasilis Zervas1 Pulmonary Department, “G Papanikolaou” General Hospital, Aristotle University of Thessaloniki, Greece

Nikolaos Katsikogiannis3 Surgery Department (NHS), University Hospital of Alexandroupolis, Greece

Nikolaos Courcoutsakis4 Radiology Department, University Hospital of Alexandroupolis, Democritus University of Thrace, Greece

Alexandros Mitrakas5 First University Surgery Department, University Hospital of Alexandroupolis, Democritus University of Thrace, Greece

Panagiotis Touzopoulos5 First University Surgery Department, University Hospital of Alexandroupolis, Democritus University of Thrace, Greece

Michael Karanikas5 First University Surgery Department, University Hospital of Alexandroupolis, Democritus University of Thrace, Greece

Konstantinos Zarogoulidis1 Pulmonary Department, “G Papanikolaou” General Hospital, Aristotle University of Thessaloniki, Greece

Aikaterini Markopoulou2 First Pulmonary Clinic, “G Papanikolaou” General Hospital, Thessaloniki, Greece

show all

Abstract

In recent years, there has been a major advance in the treatment of pulmonary hypertension. New medications are continually added to the therapeutic arsenal. The prostanoids are among the first agents used to treat pulmonary hypertension and are currently considered the most effective. This case study describes a 63-year-old man who was diagnosed with chronic thromboembolic pulmonary hypertension and successfully treated with subcutaneously administered treprostenil for 6 months before a successful pulmonary thromboendarterectomy. Treatment of chronic thromboembolic pulmonary hypertension often requires a multidisciplinary approach before surgery. Further evaluation of prostanoids is needed to define their role and time of initiation of medical therapy in these patients.

Keywords:

Acknowledgements

PZ, KP, and MK wrote the manuscript. AM, PT, MK, VZ, and NK were the surgeons who evaluated the patient. EK, EM, and MK were responsible for the patient’s medical care. NC was the radiologist who evaluated the radiographic exams. DP and TK assisted in the revision of the manuscript. KZ provided useful insights. EM was responsible for the patient’s medical treatment and provided useful insights.

Disclosure

The authors report no conflicts of interest in this work.

Pulmonary thromboendarterectomy after treatment with treprostenil in a chronic thromboembolic pulmonary hypertension patient: a case report

Information for

Open access

Opportunities

Help and information

Pulmonary thromboendarterectomy after treatment with treprostenil in a chronic thromboembolic pulmonary hypertension patient: a case report

Abstract

Acknowledgements

Disclosure

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature